Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Gross

Showing results (1121-1130 of 1,991) with videos related to

Pageof 200
Sort By:
Rheumatology (Oxford, England)|January 4, 2001
Giant cell arteritis is more prevalent in urban than in rural populations: results of an epidemiological study of primary systemic vasculitides in GermanyE Reinhold-Keller, A Zeidler, J Gutfleisch, et al.
World Health Forum|January 1, 1994
Problem-solving for better healthB Smith, S Barnett, D Collado, et al.
Gynecologic Oncology|November 1, 1994
Basic fibroblast growth factor and receptor expression in human ovarian cancerK Crickard, J L Gross, U Crickard, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 18, 2025
A systematic review of patient-reported outcome measures (PROMs) to assess health-related quality of life (HRQoL) for breast cancer patients who are undertaking adjuvant endocrine therapyRila Su, Claire Snyder, Albert W Wu, et al.
BMC Medicine|February 22, 2013
Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trialClifford J Bailey, Jorge L Gross, Delphine Hennicken, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 28, 2013
Long-term 4-year safety of saxagliptin in drug-naive and metformin-treated patients with Type 2 diabetesJ Rosenstock, J L Gross, C Aguilar-Salinas, et al.
Diabetes Research and Clinical Practice|March 28, 2006
A simplified protocol to screen for distal polyneuropathy in type 2 diabetic patientsLuciana A Costa, Jorge F Maraschin, José H Xavier de Castro, et al.
Analytical Chemistry|October 16, 2012
Native mass spectrometry characterization of intact nanodisc lipoprotein complexesMichael T Marty, Hao Zhang, Weidong Cui, et al.
Journal of the American Society for Mass Spectrometry|July 2, 2024
Distinguishing Isomeric Cyclobutane Thymidine Dimers by Ion Mobility and Tandem Mass SpectrometryHsin-Chieh Yang, Savannah S Scruggs, Mengqi Chai, et al.
The Lancet. Healthy Longevity|July 12, 2026
Differences in the prevalence and patterns of dementia risk factors across 14 countries and regions: a harmonised cross-national analysisEmma Nichols, Zachary J Kunicki, Michael Markot, et al.
Pageof 200

Showing results (1121-1130 of 1,991) with videos related to

Sort By:
Pageof 200
Rheumatology (Oxford, England)|January 4, 2001
Giant cell arteritis is more prevalent in urban than in rural populations: results of an epidemiological study of primary systemic vasculitides in GermanyE Reinhold-Keller, A Zeidler, J Gutfleisch, et al.
World Health Forum|January 1, 1994
Problem-solving for better healthB Smith, S Barnett, D Collado, et al.
Gynecologic Oncology|November 1, 1994
Basic fibroblast growth factor and receptor expression in human ovarian cancerK Crickard, J L Gross, U Crickard, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 18, 2025
A systematic review of patient-reported outcome measures (PROMs) to assess health-related quality of life (HRQoL) for breast cancer patients who are undertaking adjuvant endocrine therapyRila Su, Claire Snyder, Albert W Wu, et al.
BMC Medicine|February 22, 2013
Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trialClifford J Bailey, Jorge L Gross, Delphine Hennicken, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 28, 2013
Long-term 4-year safety of saxagliptin in drug-naive and metformin-treated patients with Type 2 diabetesJ Rosenstock, J L Gross, C Aguilar-Salinas, et al.
Diabetes Research and Clinical Practice|March 28, 2006
A simplified protocol to screen for distal polyneuropathy in type 2 diabetic patientsLuciana A Costa, Jorge F Maraschin, José H Xavier de Castro, et al.
Analytical Chemistry|October 16, 2012
Native mass spectrometry characterization of intact nanodisc lipoprotein complexesMichael T Marty, Hao Zhang, Weidong Cui, et al.
Journal of the American Society for Mass Spectrometry|July 2, 2024
Distinguishing Isomeric Cyclobutane Thymidine Dimers by Ion Mobility and Tandem Mass SpectrometryHsin-Chieh Yang, Savannah S Scruggs, Mengqi Chai, et al.
The Lancet. Healthy Longevity|July 12, 2026
Differences in the prevalence and patterns of dementia risk factors across 14 countries and regions: a harmonised cross-national analysisEmma Nichols, Zachary J Kunicki, Michael Markot, et al.
Pageof 200